Response to the FDA’s RFI on Rare Disease Clinical Trial Networks, supporting the Rare Disease Cures Accelerator Public Comments Comments provided on: July 20, 2020 Comments provided to: Food and Drug Administration (FDA) View PDF Download PDF Here
